Literature DB >> 27176570

Concerns of low-risk thyroid cancer survivors.

Anna M Sawka1, Richard W Tsang2, James D Brierley2, Lorne Rotstein3, Phillip Segal1, Shereen Ezzat4, David P Goldstein5.   

Abstract

Entities:  

Year:  2016        PMID： 27176570     DOI： 10.1080/0284186X.2016.1175661

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  5 in total

1.  Patient Experience of Thyroid Cancer Active Surveillance in Japan.

Authors:  Louise Davies; Benjamin R Roman; Mitsuhiro Fukushima; Yasuhiro Ito; Akira Miyauchi
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-04-01       Impact factor: 6.223

2.  Patients' View on the Management of Papillary Thyroid Microcarcinoma: Active Surveillance or Surgery.

Authors:  Yusaku Yoshida; Kiyomi Horiuchi; Takahiro Okamoto
Journal:  Thyroid       Date:  2020-02-06       Impact factor: 6.568

3.  Thyroid cancer patients satisfaction at the management outcome: an analysis of the results of a nationwide survey in 485 subjects.

Authors:  Juan J Díez; Juan C Galofré
Journal:  BMC Health Serv Res       Date:  2021-02-18       Impact factor: 2.655

4.  NATIONAL SURVEY OF ENDOCRINOLOGISTS AND SURGEONS REGARDING ACTIVE SURVEILLANCE FOR LOW-RISK PAPILLARY THYROID CANCER.

Authors:  Benjamin R Roman; Juan P Brito; Megan C Saucke; Shivangi Lohia; Catherine B Jensen; Nick Zaborek; Jamia Linn Jennings; Robert M Tuttle; Louise Davies; Susan C Pitt
Journal:  Endocr Pract       Date:  2020-11-17       Impact factor: 3.443

5.  Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.

Authors:  Iwao Sugitani; Yasuhiro Ito; Dai Takeuchi; Hirotaka Nakayama; Chie Masaki; Hisakazu Shindo; Masanori Teshima; Kazuhiko Horiguchi; Yusaku Yoshida; Toshiharu Kanai; Mitsuyoshi Hirokawa; Kiyomi Y Hames; Isao Tabei; Akira Miyauchi
Journal:  Thyroid       Date:  2020-11-02       Impact factor: 6.568
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.